![Andreas Klostermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Andreas Klostermann was the founder of conoGenetix biosciences GmbH, where he held the title of Chief Executive Officer from 2002 to 2017.
Dr. Klostermann is also the founder of selectION, Inc. Dr. Klostermann is currently the Director at The Education Foundation of the Forest Lake Area.
Actieve functies van Andreas Klostermann
| Bedrijven | Functie | Begin |
|---|---|---|
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology Provides a technology platform to develop peptide blockers for ion channels | Oprichter | - |
The Education Foundation of the Forest Lake Area | Directeur/Bestuurslid | - |
Eerdere bekende functies van Andreas Klostermann
| Bedrijven | Functie | Einde |
|---|---|---|
conoGenetix biosciences GmbH
 conoGenetix biosciences GmbH Pharmaceuticals: MajorHealth Technology Develops peptide-based drugs and new ion channel selective peptides | Algemeen Directeur | 01-10-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
conoGenetix biosciences GmbH
conoGenetix biosciences GmbH Pharmaceuticals: MajorHealth Technology Develops peptide-based drugs and new ion channel selective peptides | Health Technology |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology Provides a technology platform to develop peptide blockers for ion channels | Health Technology |
The Education Foundation of the Forest Lake Area |
